Patents by Inventor Erika L. Jones

Erika L. Jones has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9624555
    Abstract: Nucleic acid amplification primers and methods for specific detection of influenza A and influenza B nucleic acid targets are disclosed. The primer-target binding sequences are useful for detection of influenza A and influenza B targets in a variety of amplification and hybridization reactions. The oligonucleotide sequences are able to differentiate between influenza A and influenza B strains through specific hybridization to one or the other virus strain, enabling specific detection of the presence of influenza A and/or influenza B in a specimen.
    Type: Grant
    Filed: June 13, 2013
    Date of Patent: April 18, 2017
    Assignee: Becton, Dickinson and Company
    Inventors: Tobin Hellyer, James A. Price, Jr., Erika L. Jones
  • Publication number: 20140004502
    Abstract: Nucleic acid amplification primers and methods for specific detection of influenza A and influenza B nucleic acid targets are disclosed. The primer-target binding sequences are useful for detection of influenza A and influenza B targets in a variety of amplification and hybridization reactions. The oligonucleotide sequences are able to differentiate between influenza A and influenza B strains through specific hybridization to one or the other virus strain, enabling specific detection of the presence of influenza A and/or influenza B in a specimen.
    Type: Application
    Filed: June 13, 2013
    Publication date: January 2, 2014
    Inventors: Tobin Hellyer, James A. Price, JR., Erika L. Jones
  • Publication number: 20100273156
    Abstract: Nucleic acid amplification primers and methods for specific detection of influenza A and influenza B nucleic acid targets are disclosed. The primer-target binding sequences are useful for detection of influenza A and influenza B targets in a variety of amplification and hybridization reactions. The oligonucleotide sequences are able to differentiate between influenza A and influenza B strains through specific hybridization to one or the other virus strain, enabling specific detection of the presence of influenza A and/or influenza B in a specimen.
    Type: Application
    Filed: May 30, 2008
    Publication date: October 28, 2010
    Applicant: BECTON, DICKINSON AND COMPANY
    Inventors: Tobin Hellyer, James A. Price, JR., Erika L. Jones